Fonseca E, Nesland J M, Höie J, Sobrinho-Simões M
Department of Pathology of the Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Portugal.
Virchows Arch. 1997 Mar;430(3):239-45. doi: 10.1007/BF01324808.
The expression of simple and stratified epithelial-type cytokeratin (CK) intermediate filaments was evaluated by immunohistochemistry in a series of 41 papillary carcinomas, 10 follicular carcinomas, 2 poorly differentiated carcinomas and 34 specimens of normal thyroid parenchyma and lymphocytic thyroiditis. The aim of the study was to establish the CK profile of normal thyroid and thyroid carcinomas in order to clarify the putative application of CK immunostaining in diagnostic surgical pathology, and to evaluate whether the process of neoplastic transformation and tumour progression in the thyroid may be associated with any particular change in CK expression. Normal thyroid strongly expressed simple epithelial-type CKs 7 and 18 and, to a lesser degree, CKs 8 and 19, but did not express stratified epithelial-type CKs. The same pattern was found in lymphocytic thyroiditis, though the CK 19 immunoreactivity was stronger in these lesions than in the normal thyroid. Papillary and follicular thyroid carcinomas shared the expression of simple epithelial-type CKs 7, 8, 18 and 19. Immunoreactivity for CK 19 was frequently stronger and more widely distributed within each particular tumour in papillary than in follicular carcinomas, but it could also be detected, at least focally, in every follicular carcinoma. Strong expression of CK 19 highlighted small foci of papillary carcinoma not easily identifiable by conventional histological examination. Stratified epithelial-type CKs 5/6 and 13 were detected in a high percentage of papillary carcinomas, in contrast to their absence in follicular carcinomas and normal thyroid. The CK pattern was similar in primary and metastatic papillary carcinomas. We conclude that papillary carcinoma of the thyroid presents a distinct CK profile that may be used for diagnostic purposes.
通过免疫组织化学方法,在41例乳头状癌、10例滤泡状癌、2例低分化癌以及34例正常甲状腺实质和淋巴细胞性甲状腺炎标本中,评估了简单上皮型和复层上皮型细胞角蛋白(CK)中间丝的表达情况。本研究的目的是确定正常甲状腺和甲状腺癌的CK谱,以阐明CK免疫染色在诊断性外科病理学中的可能应用,并评估甲状腺肿瘤转化和肿瘤进展过程是否可能与CK表达的任何特定变化相关。正常甲状腺强烈表达简单上皮型CK7和CK18,程度较轻地表达CK8和CK19,但不表达复层上皮型CK。淋巴细胞性甲状腺炎中也发现了相同的模式,尽管这些病变中CK19的免疫反应性比正常甲状腺更强。甲状腺乳头状癌和滤泡状癌均表达简单上皮型CK7、CK8、CK18和CK19。在乳头状癌中,CK19的免疫反应性在每个特定肿瘤内通常比滤泡状癌更强且分布更广泛,但在每个滤泡状癌中至少也能局灶性检测到。CK19的强表达突出了常规组织学检查不易识别的乳头状癌小灶。复层上皮型CK5/6和CK13在高比例的乳头状癌中被检测到,而在滤泡状癌和正常甲状腺中未检测到。原发性和转移性乳头状癌的CK模式相似。我们得出结论,甲状腺乳头状癌呈现出一种独特的CK谱,可用于诊断目的。